Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Thacker

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bjpsych Bulletin|April 13, 2017
Psychiatry and the geriatric syndromes - creating constructive interfacesSimon Thacker, Mike Skelton, Rowan Harwood
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Alzheimer'S Research & Therapy|February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
BMJ (Clinical Research Ed.)|August 29, 2023
Promoting Activity, Independence, and Stability in Early Dementia and mild cognitive impairment (PrAISED): randomised controlled trialRowan H Harwood, Sarah E Goldberg, Andrew Brand, et al.
Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bjpsych Bulletin|April 13, 2017
Psychiatry and the geriatric syndromes - creating constructive interfacesSimon Thacker, Mike Skelton, Rowan Harwood
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Alzheimer'S Research & Therapy|February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
BMJ (Clinical Research Ed.)|August 29, 2023
Promoting Activity, Independence, and Stability in Early Dementia and mild cognitive impairment (PrAISED): randomised controlled trialRowan H Harwood, Sarah E Goldberg, Andrew Brand, et al.
Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.
Pageof 1